Table 3.

3′-UTR of urokinase gene polymorphism and clinical outcome.

	C/C (n = 82)	C/T (n = 9)	P value
Cardiovascular events	17 (20.7)	2 (22.2)	0.917
Malignancy	13 (15.9)	0 (0.0)	0.008*
Complete remission	42 (51.2)	6 (66.7)	0.641
Disease progression	47 (57.3)	3 (33.3)	0.154
ESRD	17 (20.7)	0 (0.0)	0.006*

Distribution was analyzed by Chi-square test.

*Measured by Kendall's Tau-b significant P value < 0.05.